Well.... I continue to be miffed at the deal Sprott pulled. Yes... they were smart about it, but... it stings considering the huge profit they are generating off EMR shareholders. A double shame they cannot close out the gold participation (should have had some sort of buy back option, hindsight of course). Refinancing might make sense, though, with the other debt facility, its probably not a priority.
The acquisition loan has been sitting there for a long time now. Perhaps part of the hold up, is EMR not being net cash, as in, needing a little extra fire-power to close out any deal.
EMR Price at posting:
$1.07 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)